Basket cover image
12 handpicked stocks

Defence Stocks

These carefully selected defence companies are positioned to benefit from increasing global tensions and military spending. Our professional analysts have identified stocks with potential growth from long-term government contracts and enhanced defence initiatives.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+2

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at mai 28

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

PLTR

Palantir Technologies Inc

PLTR

Current price

$157.75

LMT

Lockheed Martin Corporation

LMT

Current price

$441.10

NOC

Northrop Grumman Corporation

NOC

Current price

$586.23

About This Group of Stocks

1

Our Expert Thinking

As global conflicts escalate, governments worldwide are increasing military budgets to strengthen defence capabilities. This creates sustained demand for weapons systems, cybersecurity, and defence technology, potentially benefiting companies with established government relationships.

2

What You Need to Know

Defence stocks often show stability during economic uncertainty due to long-term government contracts. These companies typically provide essential services ranging from aerospace engineering to cybersecurity, with revenue streams that can remain consistent despite market volatility.

3

Why These Stocks

This collection features established defence contractors with strong government relationships and innovative capabilities. These handpicked companies represent diverse aspects of the defence industry, from aerospace giants to emerging tech firms specializing in security solutions.

Group Performance Snapshot

9 of 12

Stocks Rated Buy by Analysts

9 of 12 assets in this group are rated Buy by professional analysts.

0.7%

Group Growth

This group averaged a 0.7% return last month.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🌍

Global Tensions Creating Opportunity

Rising geopolitical conflicts are driving nations to increase defence budgets, potentially creating sustained demand for the products and services these companies provide.

🔒

Recession-Resistant Potential

Defence contractors often benefit from long-term government contracts that can provide revenue stability even during economic downturns, making them interesting during uncertain times.

🚀

Technology Evolution Advantage

Many of these defence companies are at the forefront of developing cutting-edge security technologies that governments increasingly need in our complex global landscape.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.